SHAPIR ENGINEERING AND INDUSTRY LTD (SPEN)
Periodic and annual report for 2025
Periodic and annual report for 2025
LexinFintech Holdings Ltd. Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results
TACTI-004 Phase III and IMP761 Phase I Updates
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering
Almonty Industries Reports Fourth Quarter and Full Year 2025 Financial Results
Vesicor Therapeutics Appoints Michael Tolentino, M.D., as Chief Executive Officer
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering
Consolidated Lithium Metals annonce la clôture de la première tranche du financement par placement privé
RYVYL Inc. Announces Postponement of Special Meeting of Shareholders
Le VinFast VF 8 et ses nombreux modes intelligents